🇺🇸 FDA
Pipeline program

nerve growth factor

NGF-TBI

Phase 2 small_molecule completed

Quick answer

nerve growth factor for Traumatic Brain Injury is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Traumatic Brain Injury
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials